Painkillers in higher doses, taken over longer periods for chronic pain increase overdose risk
the ONA take:
According to a new study published in The Journal of Pain, researchers from the School of Medicine at the University of Texas have found that painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
For the study, researchers developed a database to analyze medications, health care delivery, and comorbid conditions for over 200,000 HMO-enrolled patients who filled two or more prescriptions for opioids for non-cancer pain between 2009 and 2012. Results showed that a morphine equivalent total daily dose of 100mg or more significantly increased the risk of drug overdose.
In addition, patients who took 50-99mg/day were at an increased risk of drug overdose if they filled prescriptions totaling the morphine equivalent of at least 1,830mg over a 6-month period.
A second study published in The Journal of General Internal Medicine found that the risk of drug overdose is multiplicative if they are taking benzodiazepines on top of opioids.
The findings suggest that healthcare providers should be mindful of the drug combination that they are prescribing as well as how much opioids they have prescribed a patients over a period of time.
Painkillers in higher doses and taken over longer periods for chronic pain increase the risk of overdose.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|